Title |
Antimicrobial Drug–Resistant Shiga Toxin–Producing Escherichia coli Infections, Michigan, USA - Volume 23, Number 9—September 2017 - Emerging Infectious Diseases journal - CDC
|
---|---|
Published in |
Emerging Infectious Diseases, September 2017
|
DOI | 10.3201/eid2309.170523 |
Pubmed ID | |
Authors |
Sanjana Mukherjee, Rebekah E. Mosci, Chase M. Anderson, Brian A. Snyder, James Collins, James T. Rudrik, Shannon D. Manning |
Abstract |
High frequencies of antimicrobial drug resistance were observed in O157 and non-O157 Shiga toxin-producing E. coli strains recovered from patients in Michigan during 2010-2014. Resistance was more common in non-O157 strains and independently associated with hospitalization, indicating that resistance could contribute to more severe disease outcomes. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 38% |
Sweden | 1 | 13% |
Unknown | 4 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 75% |
Scientists | 2 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 35 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 17% |
Student > Ph. D. Student | 5 | 14% |
Student > Bachelor | 4 | 11% |
Student > Master | 4 | 11% |
Other | 2 | 6% |
Other | 5 | 14% |
Unknown | 9 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 8 | 23% |
Biochemistry, Genetics and Molecular Biology | 4 | 11% |
Immunology and Microbiology | 4 | 11% |
Medicine and Dentistry | 3 | 9% |
Mathematics | 1 | 3% |
Other | 6 | 17% |
Unknown | 9 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2017.
All research outputs
#2,257,791
of 24,464,848 outputs
Outputs from Emerging Infectious Diseases
#2,389
of 9,470 outputs
Outputs of similar age
#42,593
of 320,620 outputs
Outputs of similar age from Emerging Infectious Diseases
#36
of 117 outputs
Altmetric has tracked 24,464,848 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,470 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 45.5. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,620 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 117 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.